Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q3 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
ATR:US | AptarGroup | Common share | - | US0383361039 | $174.7 |
Company name | AptarGroup |
---|---|
Sector | Health Care / Health Care Equipment & Services / Health Care Equipment & Supplies / Health Care Supplies |
Business address | 265 Exchange Drive Suite 301 Crystal Lake, IL 60014 United States |
Mailing address | 265 Exchange Drive Suite 301 Crystal Lake, IL 60014 United States |
Website | investors.aptar.com |
Information disclosure | www.sec.gov |